Background Circle Background Circle
CDC: Mood Disorders Increase Risk for Severe COVID-19

CDC: Mood Disorders Increase Risk for Severe COVID-19

Oct. 28, 2021 — The CDC says people with certain mental health conditions could have a higher risk of more severe COVID-19, which could lead to a need for hospitalization, ICU admission, or death.

The agency added mental health disorders to its web page listing conditions that could place people at increased risk for more severe COVID-19.

As the latest addition to the agency’s COVID-19 People with Certain Medical Conditions list, mood disorders join 18 other conditions or behaviors that increase risk. The list ranges from cancer to tuberculosis, and includes people who smoke, are overweight or obese, pregnant, or immunocompromised.

The CDC says that anyone at higher risk for severe COVID-19 should work with their health care providers to carefully manage their condition. In addition, it says to get “vaccinated for COVID-19 as soon as you can, including taking boosters if and when they are recommended for you.”

Leaders from the American Psychiatric Association, American Psychological Association, and 14 other mental health organizations applauded the CDC’s actions. A joint statement cites evidence that schizophrenia in particular is only second to age as a risk factor for severe COVID-19.

“By recognizing that severe mental illness is an underlying medical condition connected to a higher risk for COVID-19, the CDC will save lives,” American Psychiatric Association CEO and Medical Director Saul Levin, MD, said in a news release.

Two studies published this year support the link between mood disorders and high risk for severe COVID-19 outcomes. In a January study in JAMA Psychiatry, patients with schizophrenia were more likely to die from COVID-19 in research that adjusted for other things that could play a role, including other medical conditions, age, race, and sex.

In another study, in July, also published in JAMA Psychiatry, researchers compiled evidence from 21 studies for people with mood disorders. This review and analysis also supports higher odds of hospitalization and death in people infected with the coronavirus during the pandemic.

Source link

You Might Also Like!
Risk of Death From COVID in Nursing Homes: Race Matters
Risk of Death From COVID in Nursing Homes: Race Matters

Ouslander agreed. "We all have a social responsibility," he said. "Just because you're not going into a nursing home," he ENGAGE+

COVID Death Risk Is 3.5 Times That of Influenza
COVID Death Risk Is 3.5 Times That of Influenza

MONDAY, Feb. 15, 2021 (HealthDay News) -- The risk of death from COVID-19 is more than triple that from seasonal ENGAGE+

CDC Says Schools Can Safely Reopen, But Will They?
CDC Says Schools Can Safely Reopen, But Will They?

Leila Kubesch, Spanish teacher, Norwood High School, Cincinnati, OH. Andrea Wader, parent; president, John C. Fremont Elementary PTA, Long Beach, ENGAGE+

Southern California Is Origin of New COVID-19 Variant
Southern California Is Origin of New COVID-19 Variant

FRIDAY, Feb. 12, 2021 (HealthDay News) -- A new variant of COVID-19 found in Southern California is coursing across the ENGAGE+

COVID-19 vaccines: Safety, side effects — and coincidence
COVID-19 vaccines: Safety, side effects — and coincidence

As the pandemic rages on, it’s increasingly clear that widespread vaccination is essential to help contain it. Physical distancing, universal ENGAGE+

Give Hospitalized COVID-19 Patients Blood Thinners
Give Hospitalized COVID-19 Patients Blood Thinners

By Robert Preidt HealthDay Reporter FRIDAY, Feb. 12, 2021 (HealthDay News) -- Giving blood thinners to COVID-19 patients soon after ENGAGE+

Health Care Heroes Share Their New Year’s Wishes | NBC Nightly News
Health Care Heroes Share Their New Year’s Wishes | NBC Nightly News

NBC News is a leading source of global news and information. Here you will find clips from NBC Nightly News, ENGAGE+

Covid-19: Vaccine as good in 'real world' as in trial in Israel
Covid-19: Vaccine as good in 'real world' as in trial in Israel

The Pfizer vaccine prevented 94% of infections in a group of 600,000 Israeli patients. Source link